WallStreetZenWallStreetZen

NASDAQ: OKUR
Onkure Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OKUR

Based on 4 analysts offering 12 month price targets for Onkure Therapeutics Inc

Min Forecast
$30.00+527.62%
Avg Forecast
$32.25+574.69%
Max Forecast
$34.00+611.3%

Should I buy or sell OKUR stock?

Based on 4 analysts offering ratings for Onkure Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OKUR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OKUR as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -9.02% per year. Learn More

Be the first to know when Wall Street analysts revise their OKUR stock forecasts and price targets.

OKUR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-18
lockedlocked$00.00+00.00%2025-03-11
lockedlocked$00.00+00.00%2025-01-28
lockedlocked$00.00+00.00%2024-12-05

1 of 1

Forecast return on equity

Is OKUR forecast to generate an efficient return?

Company
-38.76%
Industry
155.92%
Market
88.69%
OKUR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OKUR forecast to generate an efficient return on assets?

Company
-35.02%
Industry
32.62%
OKUR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OKUR earnings per share forecast

What is OKUR's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$5.12
Avg 2 year Forecast
-$3.45
Avg 3 year Forecast
-$3.31

OKUR revenue forecast

What is OKUR's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.0M
Avg 2 year Forecast
$2.0M
Avg 3 year Forecast
$2.0M

OKUR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OKUR$4.78$32.25+574.69%Strong Buy
ADAP$0.25$2.18+772.00%Buy
APLT$0.55$4.13+651.37%Buy
IKNA$1.35$4.00+196.30%Buy
VANI$1.10$4.00+263.64%Buy
View Top Biotech Stocks

Onkure Therapeutics Stock Forecast FAQ

Is Onkure Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OKUR) stock is to Strong Buy OKUR stock.

Out of 4 analysts, 1 (25%) are recommending OKUR as a Strong Buy, 3 (75%) are recommending OKUR as a Buy, 0 (0%) are recommending OKUR as a Hold, 0 (0%) are recommending OKUR as a Sell, and 0 (0%) are recommending OKUR as a Strong Sell.

If you're new to stock investing, here's how to buy Onkure Therapeutics stock.

What is OKUR's earnings growth forecast for 2025-2027?

(NASDAQ: OKUR) Onkure Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.89%.

Onkure Therapeutics's earnings in 2025 is -$52,673,000.On average, 4 Wall Street analysts forecast OKUR's earnings for 2025 to be -$68,724,250, with the lowest OKUR earnings forecast at -$69,866,295, and the highest OKUR earnings forecast at -$67,985,280. On average, 2 Wall Street analysts forecast OKUR's earnings for 2026 to be -$46,286,421, with the lowest OKUR earnings forecast at -$51,593,572, and the highest OKUR earnings forecast at -$40,979,269.

In 2027, OKUR is forecast to generate -$44,472,584 in earnings, with the lowest earnings forecast at -$50,249,989 and the highest earnings forecast at -$38,695,179.

What is OKUR's revenue growth forecast for 2025-2027?

(NASDAQ: OKUR) Onkure Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.86%.

Onkure Therapeutics's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast OKUR's revenue for 2025 to be $26,871,652, with the lowest OKUR revenue forecast at $26,871,652, and the highest OKUR revenue forecast at $26,871,652. On average, 1 Wall Street analysts forecast OKUR's revenue for 2026 to be $26,871,652, with the lowest OKUR revenue forecast at $26,871,652, and the highest OKUR revenue forecast at $26,871,652.

In 2027, OKUR is forecast to generate $26,871,652 in revenue, with the lowest revenue forecast at $26,871,652 and the highest revenue forecast at $26,871,652.

What is OKUR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: OKUR) forecast ROA is -35.02%, which is lower than the forecast US Biotechnology industry average of 32.62%.

What is OKUR's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OKUR price target, the average OKUR price target is $32.25, with the highest OKUR stock price forecast at $34.00 and the lowest OKUR stock price forecast at $30.00.

On average, Wall Street analysts predict that Onkure Therapeutics's share price could reach $32.25 by Mar 18, 2026. The average Onkure Therapeutics stock price prediction forecasts a potential upside of 574.69% from the current OKUR share price of $4.78.

What is OKUR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OKUR) Onkure Therapeutics's current Earnings Per Share (EPS) is -$15.28. On average, analysts forecast that OKUR's EPS will be -$5.12 for 2025, with the lowest EPS forecast at -$5.20, and the highest EPS forecast at -$5.06. On average, analysts forecast that OKUR's EPS will be -$3.45 for 2026, with the lowest EPS forecast at -$3.84, and the highest EPS forecast at -$3.05. In 2027, OKUR's EPS is forecast to hit -$3.31 (min: -$3.74, max: -$2.88).

What is OKUR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: OKUR) forecast ROE is -38.76%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.